SLI
2 008,39
|
5,00
|
0,25 %
|
Analysen zu SLI-Werten
16.05.25 | Richemont Outperform | Bernstein Research | |
16.05.25 | Swiss Re Hold | Jefferies & Company Inc. | |
16.05.25 | Zurich Insurance Sell | UBS AG | |
15.05.25 | Givaudan Neutral | UBS AG | |
15.05.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
15.05.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
12.05.25 | UBS Buy | Deutsche Bank AG | |
12.05.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
09.05.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
09.05.25 | Roche Buy | UBS AG | |
09.05.25 | Richemont Buy | UBS AG | |
09.05.25 | ABB Neutral | UBS AG | |
08.05.25 | ABB Sector Perform | RBC Capital Markets | |
08.05.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
08.05.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
08.05.25 | ams-OSRAM Buy | Deutsche Bank AG | |
08.05.25 | Zurich Insurance Sell | UBS AG | |
07.05.25 | Roche Underweight | JP Morgan Chase & Co. | |
07.05.25 | ABB Neutral | Goldman Sachs Group Inc. | |
06.05.25 | Richemont Overweight | JP Morgan Chase & Co. | |
05.05.25 | UBS Kaufen | DZ BANK | |
02.05.25 | ams-OSRAM Buy | Hauck Aufhäuser Lampe Privatbank AG | |
02.05.25 | Richemont Neutral | Goldman Sachs Group Inc. | |
02.05.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
02.05.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.05.25 | ams-OSRAM Equal Weight | Barclays Capital | |
01.05.25 | UBS Buy | Goldman Sachs Group Inc. | |
01.05.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
01.05.25 | ams-OSRAM Buy | UBS AG | |
01.05.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
30.04.25 | Novartis Buy | Deutsche Bank AG | |
30.04.25 | Novartis Kaufen | DZ BANK | |
30.04.25 | UBS Outperform | RBC Capital Markets | |
30.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
30.04.25 | UBS Hold | Jefferies & Company Inc. | |
30.04.25 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
30.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
29.04.25 | Novartis Hold | Jefferies & Company Inc. |